-
It is unclear to what extent interarm blood pressure (BP) differences are reproducible vs the result of random error. The present study was designed to resolve this issue.
Archives of Internal Medicine (Angiologia) - Mar, 27 Febbraio 2007

http://archinte.ama-assn.org/
-
A new study suggests long-term outcome of stenting intracranial arteries in patients with symptomatic stenosis may improve outcomes at 1 and 2 years over previously published results with anticoagulation and antiplatelet therapy.
Medscape (Angiologia) - Mar, 13 Febbraio 2007

http://www.medscape.com
-
Although the roles of clotting proteins and enzymes that activate or inhibit fibrin production and lysis are well characterized, the underlying contribution of genetic variation in these constituents to risk of venous thrombosis (VT) has not been fully investigated.
Journal of the American Medical Association (Angiologia) - Mar, 6 Febbraio 2007

http://jama.ama-assn.org/
-
Inflammatory abdominal aortic aneurysm (AAA) accounts for 5% to 10% of all cases of AAA and differs from typical atherosclerotic AAA in many important ways.
Journal of the American Medical Association (Angiologia) - Gio, 25 Gennaio 2007

http://jama.ama-assn.org/
-
According to some studies on animals it seems that the renin-angiotensin system comes into play in favouring the formation of abdominal aortic aneurysms (AAA); consequently, the use of ACE-inhibitors could be able to prevent their formation and progression.
MedNews (Angiologia) - Mer, 24 Gennaio 2007

http://mn.medsurfnews.com/
-
Homozygous familial hypercholesterolemia is a serious disorder resulting in early-onset vascular disease. This preliminary study explored a new therapy, an inhibitor of microsomal triglyceride transfer protein, which was very effective in lowering low-density lipoprotein cholesterol levels.
New England Journal of Medicine (Angiologia) - Mar, 16 Gennaio 2007

http://www.nejm.org
-
In the last decade, thromboembolism therapy has seen the shift from the use of unfractionated heparin administered by endovenous route and low-molecular-weight heparin injected under the skin, presenting the advantage of being injected also at home and of not having the need of a coagulation laboratory monitoring.
MedNews (Angiologia) - Ven, 22 Dicembre 2006

http://mn.medsurfnews.com/
-
Clinicians informed of the possibility of delayed onset of heparin-induced thrombocytopenia and thrombosis, which can occur up to several weeks after the discontinuation of heparin therapy.
Food and Drug Administration (Angiologia) - Mar, 12 Dicembre 2006

http://www.fda.gov
-
Treatment of essential thrombocythemia depends on the risk of blood clots or bleeding episodes.
MayoClinic.com (Angiologia) - Lun, 6 Novembre 2006

http://www.mayoclinic.com